and 
Series Overview
Target Audience
Commercial Support Acknowledgement
Learning Objectives for the Series
Course Directors
Faculty
Obtaining CME Credit for Archived Sessions: Important Information
Archived Session Topics and Speakers
Hardware/Software Notice
Accreditation Statement/Credit Designation Statement
Disclosures
Disclosure of Unlabeled Use
Disclaimer
Return to Main Page
The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to announce the extension of this ground-breaking CME activity. Mirroring academic grand rounds programs, these CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The "HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania" is delivered live via the Internet weekly and archived for on-demand viewing twenty-four hours after each live broadcast.
Presentations cover the most important and current topics in HIV/AIDS and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing HIV clinicians and many are case-based. The final 10 minutes of each one-hour activity consists of a question and answer period. These weekly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.
Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/grandrounds for easy access.
This educational activity is designed for HIV specialists, Infectious Disease specialists, Internal Medicine specialists, Family Practice physicians, Dermatologists, Osteo-specialists, Nephrologists, Hematology/oncologist, Psychiatrists, Public Health professionals, OB/GYN physicians and other clinicians interested and involved in the care of patients with HIV/AIDS.
These activities are supported by educational grants from Gilead Sciences and Janssen Therapeutics.
Upon completion of the educational activity participants should be able to:
|
John Bartlett, MD |
|
Calvin J. Cohen, MD, MS Research Director, CRI New England Clinical Instructor, Harvard Medical School Boston, Massachusetts |
![]() |
Ian Frank, MD Professor of Medicine, Director, Antiretroviral Clinical Research University of Pennsylvania Philadelphia, Pennsylvania |
|
Jay Kostman, MD Clinical Associate Professor of Medicine Division of Infectious Diseases Chief, Infectious Diseases Division, Penn Presbyterian Medical Center University of Pennsylvania Philadelphia, Pennsylvania |
K. Rajender Reddy, MD Professor of Medicine, Professor of Medicine in Surgery, Director of Hepatology, Medical Director of Liver Transplantation University of Pennsylvania School of Medicine Philadelphia, Pennsylvania |
|
|
Vincent Lo Re, III, MD Clinical Associate Professor of Medicine, Division of Infectious Diseases Penn Presbyterian Medical Center University of Pennsylvania Philadelphia, Pennsylvania |
Robert Siliciano, MD, PhD Professor of Medicine, Molecular Biology and Genetics, Howard Hughes Medical Institute Johns Hopkins University School of Medicine Baltimore, Maryland |
|
|
Priscilla Hsue, MD Associate Professor of Medicine, Division of Cardiology University of California, San Francisco School of Medicine San Francisco, California |
Louis J. Picker, MD Associate Director, Vaccine and Gene Therapy Institute Head, Pathobiology and Immunology Division Oregon Health and Science University Portland, Oregon |
|
|
Timothy Wilkin, MD, MPH Associate Professor of Medicine, Division of Infectious Diseases Weill Medical College of Cornell University New York, New York |
David Wohl, MD Associate Professor of Medicine, Division of Infectious Diseases, School of Medicine, The University of North Carolina, Chapel Hill, North Carolina Co-Director of HIV Services for the North Carolina Department of Corrections Chapel Hill, North Carolina |
|
|
Steven G. Deeks, MD Professor of Medicine, University of California, San Francisco San Francisco, California |
Pablo Tebas, MD Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania |
|
|
Todd Barton, MD Associate Professor of Medicine, The Perelman School of Medicine at the University of Pennsylvania Philadelphia, Pennsylvania |
Ian McGowan MD Professor of Medicine, Division of Gastroenterology, Hepatology and Nutrition University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania |
|
|
Chloe L. Thio, MD Professor of Medicine, Division of Infectious Diseases John Hopkins University Baltimore, Maryland |
Renslow Sherer, MD Professor of Medicine, Section of Infectious Diseases and Global Health, University of Chicago Chicago, Illinois |
|
|
Charles Hicks, MD Professor of Medicine Department of Infectious Diseases Duke University Medical Center Durham, North Carolina |
Beatrice Hahn, MD Professor of Medicine and Microbiology University of Pennsylvania Philadelphia, Pennsylvania |
|
|
Robert M. Grant, MD, MPH Betty Jean and Hiro Ogawa Endowed Investigator Gladstone Institute of Virology and Immunology Associate Professor of Medicine University of California, San Francisco San Francisco, California |
George M. Shaw, MD PhD Professor of Medicine Division of Hematology / Oncology University of Pennsylvania Philadelphia, Pennsylvania |
|
|
Robert Gross, MD, MSCE Associate Professor of Medicine Infectious Diseases Division Associate Professor of Epidemiology Department of Biostatistics and Epidemiology University of Pennsylvania Perelman School of Medicine Philadelphia, Pennsylvania |
Doreen Ramogola-Masire, MD Country Director and Lead Physician Women's Health Botswana UPenn Partnership Gaborone, Botswana |
|
|
James D. Neaton, PhD Professor of Biostatistics University of Minnesota School of Public Health Minneapolis, Minnesota |
Una O'Doherty MD PhD Associate Professor of Pathology and Laboratory Medicine The Hospital of the University of Pennsylvania Philadelphia, Pennsylvania |
|
|
Michel C. Nussenzweig PhD Sherman Fairchild Professor Rockefeller University Investigator, HHMI laboratory of Molecular Immunology New York, New York |
Valerianna Amorosa MD Chief of Infectious Diseases, VAMC Assistant Professor of Clinical Medicine The Perelman SOM at the University of Pennsylvania Philadelphia, Pennsylvania |
|
|
Michael R. Betts, PhD Assistant Professor Department of Microbiology Perelman School of Medicine University of Pennsylvania |
Chris Beyrer MD MPH Professor Director, Johns Hopkins Fogarty AIDS International Training and Research Program Director, Johns Hopkins Center for Public health and Human Rights Senior Scientific Liaison, HIV Vaccine Trials Network Associate Director of Public Health, Johns Hopkins Center for Public Health Baltimore, Maryland |
|
|
Daniel Kuritzkes MD Chief, Division of Infectious Diseases Brigham and Women's Hospital Professor of Medicine, Harvard Medical School Boston, Massachusetts |
Thomas Coyne MD PhD Department of Pathology Hospital of the University of Pennsylvania Philadelphia, Pennsylvania |
|
|
Jeffrey Hafkin MD Fellow, Infectious Diseases Perelman School of Medicine at the University of Pennsylvania Philadelphia, Pennsylvania |
Amy Pruitt MD Associate Professor of Neurology Hospital at the University of Pennsylvania Philadelphia, Pennsylvania |
|
|
Ronald L. Wolf MD PhD Associate Professor of Radiology Hospital of the University of Pennsylvania Philadelphia, Pennsylvania |
Corey Casper MD MPH Associate Member, Vaccine and Infectious Disease, Public Health Science and Clinical Research Divisions Fred Hutchinson Cancer Research Center Associate Professor of Medicine, Epidemiology and Global Health University of Washington Medical Director of Infection Control, Seattle Cancer Care Alliance Seattle, Washington |
|
|
Marshall J. Glesby MD PhD Associate Professor of Medicine and Associate Professor of Public Health Weill Cornell Medical College Associate attending Physician New York-Presbyterian Hospital New York, New York |
David M. Margolis, M.D. Professor of Medicine, Microbiology and Immunology, Epidemiology Director, Program in Translational Clinical Research IGHID University of North Carolina at Chapel Hill Chapel Hill, North Carolina |
|
|
Peter W. Hunt MD Assistant Professor in Residence University of California, San Francisco San Francisco, California |
Domenico Mavilio, MD, PhD Group Leader, Clinical and Experimental Immunology Instituto Clinico Humanitas Rozzano, Milano Italy |
|
|
Luis Montaner DVM MSc DPhil Wistar Institute Professor of Medicine Director, HIV-1 Immunopathogenesis Laboratory The Wistar Institute Philadelphia, Pennsylvania |
Paul E. Sax MD Clinical Director, Division of Infectious Diseases Brigham and Women's Hospital Associate Professor of Medicine Harvard Medical School Boston, Massachusetts |
|
|
Roy M. Gulick MD Chief of the Division of Infectious Diseases Professor of Medicine Weill Medical College Cornell University New York, New York |
Lawrence Corey MD President and Director Fred Hutchinson Cancer Research Center Professor, Medicine and Laboratory Medicine University of Washington Seattle, Washington |
|
|
Vincent Lo Re III MD Clinical Associate Professor of Medicine, Division of Infectious Diseases Penn Presbyterian Medical Center Perelman School of Medicine at the University of Pennsylvania Philadelphia, Pennsylvania |
Jay R. Kostman MD Clinical Associate Professor of Medicine Division of Infectious Diseases Chief, Infectious Diseases Division, Penn Presbyterian Medical Center Philadelphia, Pennsylvania |
|
|
Mark Sulkowski MD Associate Professor of Medicine and Medical Director, Viral Hepatitis Center John Hopkins University School of Medicine Baltimore, Maryland |
Myron S. Cohen MD J. Herbert Bate Professor Medicine, Microbiology and Immunology and Epidemiology The University of North Carolina at Chapel Hill Chapel Hill, North Carolina |
|
After clicking this button a new window will open and you will be redirected to the University of Pennsylvania Office of CME website for this activity.
|
John Bartlett, MD |
Jay Kostman, MD |
Robert Siliciano, MD |
Todd Barton, MD |
|
Chloe L. Thio, MD |
Geroge M. Shaw, MD PhD |
Doreen Ramogola-Masire, MD |
James D. Neaton, PhD |
|
Michel C. Nussenzweig, MD PhD |
Valeriana Amorosa, MD |
Chris Beyrer MD MPH |
Reuben S. Harris PhD |
|
Ian McGowan, MD |
Una O'Doherty MD PhD |
Thomas Coyne MD PhD |
Jeffrey Hafkin MD |
|
Amy Pruitt MD |
Ronald L. Wolf MD PhD |
Corey Casper MD MPH |
Myrone S. Cohen |
|
Name |
Commercial Supporter |
Relationship |
|
|
|
|
|
|
|
Calvin Cohen, MD |
Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec; ViiV |
Contracted Research |
|
|
Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec; Abbott |
Consulting Fees |
||
|
Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec |
Speakers Bureaus |
||
|
|
|
|
|
|
Ian Frank, MD |
GlaxoSmithKline |
Contracted Research |
|
|
Gilead |
Consulting Fees |
||
|
|
|
|
|
|
Vincent Lo Re, III, MD |
AstraZeneca, Bristol-Myers Squibb |
Contracted Research |
|
|
|
|
|
|
|
K. Rajender Reddy, MD |
Gilead, Merck, Tibotec, Vertex |
Advisory Board |
|
|
Boehringer-Ingelheim, Bristol-Myers Squibb, Merck, Tibotec, Vertex |
Contracted Research |
||
|
|
|
|
|
|
Priscilla Hsue, MD |
Bristol-Myers Squibb, Gilead |
Speakers Bureau |
|
|
|
|
|
|
|
Louis Picker, MD |
CMV Vector Technology |
Contracted Research |
|
|
|
|
|
|
|
Timothy Wilkin, MD |
GlaxoSmithKline |
Contracted Research |
|
|
|
|
|
|
|
David Wohl, MD |
Merck & Co.; GlaxoSmithKline |
Contracted Research |
|
|
Tibotec; Gilead; Bristol-Myers Squibb; Abbott |
Consulting Fees |
||
|
|
|
|
|
|
Steven Deeks, MD |
Merck & Co.; Gilead Sciences |
Contracted Research |
|
|
Tobira; ViiV |
Consulting Fees |
||
|
|
|
|
|
|
Pablo Tebas, MD |
GlaxoSmithKline |
Adjudication Committee |
|
|
Cytheris |
DSMB Committee |
||
|
GlaxoSmithKline; BMS; Gilead; Pfizer; Vertex; Inovio |
Contracted Research |
||
|
|
|
|
|
|
Renslow Sherer, MD |
BMS |
Grant Support for Research |
|
|
Abbott |
Grant Support for Research |
||
|
Gilead |
Advisory Board with Honoraria |
||
|
Abbott |
Advisory Board with Honoraria |
||
|
|
|
|
|
|
Robert M. Grant |
Gilead - Donation of study drug for NIH funded research |
Investigator |
|
|
|
|
|
|
|
Robert Gross, MD, MSCE |
BMS |
Research Investigator |
|
|
|
|
|
|
| Daniel R. Kuritzkes MD | Abbott, BSC, Boehringer-Ingelheim, Gilead, Merck, Roche & ViiV |
Consultant |
|
| Gilead & Merclk | Principal Investigator | ||
| Roche | Speaker | ||
|
|
|
|
|
| Marshall J. Glesby MD PhD | Pfizer; SIGA Technologies | Consultant | |
| Pfizer | Clinical Trial Researcher | ||
|
|
|
|
|
| David M. Margolis MD | Merck, BMS, Gilead, GSK | Research & Materials Funding | |
| Gilead | Common Stocki | ||
| Merck, BMS, GSK, Chimerix, Boehringer, ViiV | Consulting Honaria | ||
| Argos, Tibotec | Clinical Trial Funding | ||
|
|
|
|
|
| Peter W. Hunt MD | Merck | Consultant | |
| Pfizer, Salix, Roche | Investigator-Initiated Study | ||
| Boehringer-Ingelheim, Gilead | Speaker | ||
|
|
|
|
|
| Luis J. Montaner DVM MSc DPhil | Pfizer | Research Investigator | |
|
|
|
|
|
| Paul E. Sax, MD | Abbott, Aileron, BMS, Gilead, GSK, Merck, Tibotec | Consultant | |
| BMS, Gilead, Merck, GSK, Tibotec | Hospital Grant | ||
|
|
|
|
|
| Roy M. Gulick MD MPH | BMS, Gilead, Janssen | Ad-hoc Consultant (honorarium) | |
|
|
|
|
|
| Lawrence Corey MD | Immune Design Corp | Stock holder; Scientific Advisory Board | |
|
|
|
|
|
| Vincent Lo Re III MD | AstraZeneca, Bristol-Myers Squibb |
Contracted Research |
|
|
|
|
|
|
| Jay Kostman MD | Vertex | Consultant | |
| Merck | Consultant | ||
|
|
|
|
|
| Mark Sulkowski MD | Abbott, BMS, Gilead, Janssen, Merck,Roche, Vertex, Boehringer Ingelheim | Research Gra nt to John Hopkins University (PI) | |
| Abbott, BMS, Gilead, Janssen, Merck,Roche, Vertex, Boehringer Ingelheim | Scientific Advisory Panel |
| Product | Investigational and / or Off-label Use |
|
Amy Pruitt MD |
|
| methohexate, Rituxan, Tenodex | Treatment of primary CNS lymphoma |
|
|
|
| Peter W. Hunt MD | |
| Dr. Hunt indicated that: | His presentation will contain discussion of ongoing research studies of drugs targeting immune activation in treated HIV infection with the understanding that these developments cannot yet be recommended for clinical use as there is no evidence to support their use at this time. |
|
|
|
| Luis J. Montaner DVM MSc DPhil | |
| Interferon-alpha 2a (Roche/Genentech) | Ind for HIV mono-infected |
|
|
|
| Roy M. Gulick MD MPH | Investigational Antiretroviral Drugs (multiple) |
|
|
|
| Jay Kostman MD | |
| Telaprevir | Co-infection |
| Boceprevir | Co-infection |
|
|
|
| Mark Sulkowski MD | Multiple experimental HCV agents |
|
![]() |

